USE OF MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENTS TO SCREEN FOR DOWNS-SYNDROME

被引：35

作者：

KNIGHT, GJ

PALOMAKI, GE

HADDOW, JE

机构：

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 1988年 / 31卷 / 02期

关键词：

D O I：

10.1097/00003081-198806000-00009

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：306 / 327

页数：22

共 22 条

[1]

BAUMGARTEN A, 1985, LANCET, V1, P1280

[2]

BRAMBATI B, 1986, LANCET, V2, P165

[3]

CANICK JA, 1987, BR J OBSTET GYNAECOL, V95

[4]

CUCKLE HS, 1984, LANCET, V1, P926

[5] ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL [J].

CUCKLE, HS ;

WALD, NJ ;

THOMPSON, SG .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05) :387-402

[6] VERY LOW VERSUS UNDETECTABLE MATERNAL SERUM ALPHA-FETOPROTEIN VALUES AND FETAL DEATH [J].

HADDOW, JE ;

HILL, LE ;

PALOMAKI, GE ;

KNIGHT, GJ .

PRENATAL DIAGNOSIS, 1987, 7 (06) :401-406

[7]

HADDOW JE, 1981, CLIN CHEM, V27, P133

[8]

HERSHEY DW, 1986, OBSTET GYNECOL, V68, P177

[9] CHROMOSOMAL ABNORMALITY RATES AT AMNIOCENTESIS AND IN LIVE-BORN INFANTS [J].

HOOK, EB ;

CROSS, PK ;

SCHREINEMACHERS, DM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (15) :2034-2038

[10]

KLOZA EM, 1987, LANCET, V2, P275

← 1 2 3 →